Education
About Us
Working with TipRanks
Follow Us
Dermapharm Holding SE (DE:DMP)
XETRA:DMP
RESEARCH TOOLSreports
DMP Stock Chart & Stats
Day’s Range― - ―
52-Week Range€30.15 - €41.85
Previous CloseN/A
Volume747.00
Average Volume (3M)20.49K
Market Cap
€2.08B
Enterprise Value€2.79B
Total Cash (Recent Filing)€82.27M
Total Debt (Recent Filing)€495.00M
Price to Earnings (P/E)22.9
Beta0.50
Next Earnings
Apr 09, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 28, 2024Dividend Yield2.28%
Share Statistics
EPS (TTM)1.68
Shares Outstanding53,840,000
10 Day Avg. Volume21,762
30 Day Avg. Volume20,491
Standard Deviation0.10
R-Squared0.10
Alpha0.00485
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€50.00Price Target Upside29.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Dermapharm Holding SE News
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDermapharm Holding SE released a strong set of 3Q24 results with significant beats on sales and earnings.
Growth In Branded PharmaceuticalsReturn to growth in Branded Pharmaceuticals supported by Montavit contributions, reaching an adjusted EBITDA margin of 40.9%.
Operational Cash FlowOperational cash flow improved significantly by 15% year-over-year, signaling healthier company finances.
Bears Say
Arkopharma DemandWeak consumer behavior in France is negatively impacting Arkopharma demand.
Consumer Behavior In FranceWeak consumer behavior in France continues to weigh on Other Healthcare Products where top-line came in at €80m, down 10% year-over-year.
Healthcare Product MarginsOther Healthcare Products reported a margin of just 12.4%, reflecting ongoing challenges in that segment.
---
Options Prices
Currently, No data available
---
Ownership Overview
73.74% Insiders
2.49% Mutual Funds
― Other Institutional Investors
22.19% Public Companies and
Individual Investors
DMP FAQ
What was Dermapharm Holding SE’s price range in the past 12 months?
Dermapharm Holding SE lowest stock price was €30.15 and its highest was €41.85 in the past 12 months.
What is Dermapharm Holding SE’s market cap?
Dermapharm Holding SE’s market cap is €2.08B.
When is Dermapharm Holding SE’s upcoming earnings report date?
Dermapharm Holding SE’s upcoming earnings report date is Apr 09, 2025 which is in 36 days.
How were Dermapharm Holding SE’s earnings last quarter?
Dermapharm Holding SE released its earnings results on Nov 14, 2024. The company reported €0.6 earnings per share for the quarter, beating the consensus estimate of N/A by €0.6.
Is Dermapharm Holding SE overvalued?
According to Wall Street analysts Dermapharm Holding SE’s price is currently Undervalued.
Does Dermapharm Holding SE pay dividends?
Dermapharm Holding SE pays a Annually dividend of €0.879 which represents an annual dividend yield of 2.28%. See more information on Dermapharm Holding SE dividends here
What is Dermapharm Holding SE’s EPS estimate?
Dermapharm Holding SE’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dermapharm Holding SE have?
Dermapharm Holding SE has 53,840,000 shares outstanding.
What happened to Dermapharm Holding SE’s price movement after its last earnings report?
Dermapharm Holding SE reported an EPS of €0.6 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.626%.
Which hedge fund is a major shareholder of Dermapharm Holding SE?
Currently, no hedge funds are holding shares in DE:DMP
---
Dermapharm Holding SE Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€50.00 (29.53% Upside)
€50.00 (29.53% Upside)
Insider Transactions
Bought Shares
Worth €58.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.53%
12-Months-Change
Fundamentals
Return on Equity
16.04%
Trailing 12-Months
Asset Growth
-1.68%
Trailing 12-Months
Company Description
Dermapharm Holding SE
Dermapharm Holding SE is a manufacturer of patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs and natural remedies. Its portfolio of products includes cosmetics, nutritional supplements and diet and medical devices.
---
DMP Stock 12 Month Forecast
Average Price Target
€50.00
▲(29.53% Upside)
Technical Analysis
Best Analysts Covering DMP
1 Year
1 Year Success Rate
4/10 ratings generated profit
1 Year Average Return
-0.97%
reiterated a buy rating 3 months ago
Copying Gerhard Orgonas's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -0.97% per trade.
---